This funding opportunity supports milestone-driven research advancing innovative HIV prevention interventions through phased R61/R33 awards. The R61 phase focuses on development, refinement, and pilot testing of novel or enhanced strategies, while the R33 phase supports expanded testing and evaluation of interventions that address alcohol use and related comorbidities, including effectiveness, implementation, scalability, and sustainability in diverse populations and settings.
Eligible applicants include a wide range of government entities, educational institutions, tribal governments and organizations, nonprofits, for-profit organizations, small businesses, faith-based and community organizations, and regional organizations.
